Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New uterine drain shows promise in reducing Post-C-Section bleeding

NCT ID NCT06219538

Disease control Sponsor: Raydiant Oximetry, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new device called the DAISY uterine drain, which uses gentle suction to remove blood from the uterus after a C-section. Ten women having planned C-sections received the drain, and five surgeons provided feedback on how easy it was to use. The goal was to see if the device could help prevent heavy bleeding after delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

May 2024

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The participants consist of women undergoing planned CD for reasons unrelated to this study. Exclusion Criteria: * Known intrauterine or cervical pathology that would interfere with device placement and/or use * Ongoing intrauterine pregnancy * Untreated uterine rupture * Unresolved uterine inversion * Current cervical cancer * Current purulent infection of vagina, cervix, or uterus * Retained products of conception * Arterial bleeding requiring surgical or angiographic embolization * Indication for hysterectomy * Lack of study consent or unable to provide informed consent, * Any condition (temporary or permanent) in which the investigator or user deems the patient unsuitable for the study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postpartum Hemorrhage Uterine Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean section complications Post partum hemorrhage Uterine atony with hemorrhage Uterine bleeding

Contacts and locations

Locations

  • Eastern Virginia Medical School

    Norfolk, Virginia, 23507, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.